Top

Published in:

01-08-2014 | Review Article

RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research

Authors: Rachel Thompson, M.Chem., Louise Johnston, Ph.D., Domenica Taruscio, PhD, M.D., Lucia Monaco, Ph.D., Christophe Béroud, PharmD, Ph.D., Ivo G. Gut, Ph.D., Mats G. Hansson, Ph.D., Peter-Bram A. ’t Hoen, Ph.D., George P. Patrinos, PhD, Hugh Dawkins, Ph.D., Monica Ensini, Ph.D., Kurt Zatloukal, M.D., David Koubi, Ph.D., Emma Heslop, M.Sc., Justin E. Paschall, M.A., Manuel Posada, Ph.D., Peter N. Robinson, M.D., Ph.D., Kate Bushby, M.D., F.R.C.P., Hanns Lochmüller, Ph.D., M.D.

Published in: Journal of General Internal Medicine | Special Issue 3/2014

ABSTRACT

Research into rare diseases is typically fragmented by data type and disease. Individual efforts often have poor interoperability and do not systematically connect data across clinical phenotype, genomic data, biomaterial availability, and research/trial data sets. Such data must be linked at both an individual-patient and whole-cohort level to enable researchers to gain a complete view of their disease and patient population of interest. Data access and authorization procedures are required to allow researchers in multiple institutions to securely compare results and gain new insights. Funded by the European Union’s Seventh Framework Programme under the International Rare Diseases Research Consortium (IRDiRC), RD-Connect is a global infrastructure project initiated in November 2012 that links genomic data with registries, biobanks, and clinical bioinformatics tools to produce a central research resource for rare diseases.

Gut IG. New sequencing technologies. Clin Transl Oncol. 2013;15(11):879–81.PubMedCrossRef

Aymé S., Rodwell C., eds., 2013 Report on the State of the Art of Rare Disease Activities in Europe, July 2013.

Bushby K, Lochmüller H, Lynn S & Straub V. Interventions for muscular dystrophy: molecular medicines entering the clinic. Lancet 374, 2009;28:1849–56.

Tremblay JP, Xiao X, Aartsma-Rus A, et al. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther. 2013;21(2):266–8.PubMedCentralPubMedCrossRef

The International Cancer Genome Consortium. International network of cancer genome projects. Nature 464, 2010;15:993–98.

International Rare Disease Research Consortium (IRDiRC) Policies and Guidelines [pdf]. Available at: http://www.irdirc.org/wp-content/uploads/2013/06/IRDiRC_Policies_Longversion_24May2013.pdf. Accessed April 1, 2014.

Commission E. Rare diseases—How Europe is meeting the challenges. Luxembourg: Publications Office of the European Union; 2013.

’t Hoen PA, Friedländer MR, Almlöf J. Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories. Nat Biotechnol. 2013;31(11):1015–22.PubMedCrossRef

Church DM, Lappalainen I, Sneddon TP, et al. Public data archives for genomic structural variation. Nat Genet. 2010;42(10):813–4.PubMedCentralPubMedCrossRef

10.

Groth P, Gibson A, Velterop J. The anatomy of a nanopublication. Information Services and Use. 2010;30:51–6.

11.

Patrinos GP, Cooper DN, van Mulligen E, Gkantouna V, Tzimas G, Tatum Z, Schultes E, Roos M, Mons B. Microattribution and nanopublication as means to incentivize the placement of human genome variation data into the public domain. Hum Mutat. 2012;33(11):1503–12.PubMedCrossRef

12.

Giardine B, Borg J, Higgs DR, et al. Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach. Nat Genet. 2011;43(4):295–301.PubMedCrossRef

13.

Firth HV, Richards SM, Bevan AP, et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet. 2009;84(4):524–33.PubMedCentralPubMedCrossRef

14.

Yuille M, van Ommen GJ, Bréchot C, et al. Biobanking for Europe. Brief Bioinform. 2008;9(1):14–24.PubMedCrossRef

15.

Crosswell LC, Thornton JM. ELIXIR: a distributed infrastructure for European biological data. Trends Biotechnol. 2012;30(5):241–2.PubMedCrossRef

16.

Editorial. Open to interpretation. Nat Biotechnol. 2013;31 (8):661.

17.

Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v. 2.0: the next generation in gene variant databases. Hum Mutat. 2011;32(5):557–63.PubMedCrossRef

18.

Tuffery-Giraud S, Béroud C, Leturcq F, et al. Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat. 2009;30(6):934–45.PubMedCrossRef

19.

Frédéric MY, Lalande M, Boileau C, et al. UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity – application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2. Hum Mutat. 2009;30(6):952–9.PubMedCrossRef

20.

Robinson P, Köhler S, Oellrich A et al. Improved exome prioritization of disease genes through cross species phenotype comparison. Genome Res. 2013 Oct 25. [E-pub ahead of print].

21.

Brudno M, Gîrdea M, Buske O et al. PhenomeCentral: An Integrated Portal for Sharing and Searching Patient Phenotype Data for Rare Genetic Disorders. Figshare. http://dx.doi.org/10.6084/m9.figshare.939458

22.

Hunter AA, Macgregor AB, Szabo TO, Wellington CA, Bellgard MI. Yabi: An online research environment for grid, high performance and cloud computing. Source Code Biol Med. 2012;7(1):1.PubMedCentralPubMedCrossRef

23.

Lopes P, Oliveira JL. COEUS: “semantic web in a box” for biomedical applications. J Biomed Semantics. 2012;3(1):11.PubMedCentralPubMedCrossRef

24.

Lopes P & Oliveira JL. An innovative portal for rare genetic diseases research: The semantic Disease card. J Biomed Inform. 2013; 21. [epub ahead of print]

25.

Hall D, Huerta MF, McAuliffe MJ, Farber GK. Sharing heterogeneous data: the national database for autism research. Neuroinformatics. 2012;10(4):331–9.PubMedCrossRef

26.

Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB, the European Huntington’s Disease Network Tio. Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY. PLOS Currents Huntington Disease. 2010 Sep 28. Edition 1

27.

Lochmüller H, Aymé S, Pampinella F, et al. The Role of Biobanking in Rare Diseases: European Consensus Expert Group Report. Biopreservation and Biobanking. 2009;7(3):155–56.PubMedCrossRef

28.

Roos M, Marshall MS, Gibson AP et al. Structuring and extracting knowledge for the support of hypothesis generation in molecular biology. BMC Bioinformatics. 2009;1;10 Suppl 10:S9

29.

Köhler S, Doelken SC, Mungall CJ. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucl. Acids Res. 2013. doi:10.1093/nar/gkt1026.PubMedCentralPubMed

30.

Girdea M, Dumitriu S, Fiume M, et al. PhenoTips: patient phenotyping software for clinical and research use. Hum Mutat. 2013;34(8):1057–65.PubMedCrossRef

31.

Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Ayme S. Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users. Hum Mutat. 2012;33(5):803–8.PubMedCrossRef

32.

Bushby K, Lynn S, Straub V. Collaborating to bring new therapies to the patient—the TREAT-NMD model. Acta Myol. 2009;28(1):12–15.PubMedCentralPubMed

33.

McCormick J, Mehta G, Olesen HV, Viviani L, Macek M Jr, Mehta A. European Registry Working Group. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet. 2010;375(9719):1007–13.PubMedCrossRef

34.

Tabrizi SJ, Scahill RI, Owen G, et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 2013;12(7):637–49.PubMedCrossRef

35.

Global Rare Diseases Patient Registry and Data Repository. CDE Overview. Available at: https://grdr.ncats.nih.gov/index.php?option = com_content&view = article&id = 3&Itemid = 5 Accessed 15 April 2014

36.

Lochmüller H, Schneiderat P. Biobanking in rare disorders. Adv Exp Med Biol. 2010;686:105–13.PubMedCrossRef

37.

Filocamo M, Baldo C, Goldwurm S, et al. Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases. Orphanet J Rare Dis. 2013;8(1):129.PubMedCentralPubMedCrossRef

38.

Hansson MG, van Ommen GJ, Chadwick R, Dillner J. Patients would benefit from simplified ethical review and consent procedure. Lancet Oncol. 2013;14(6):451–3.PubMedCrossRef

39.

Bellgard M, Beroud C, Parkinson K, et al. Dispelling myths about rare disease registry system development. Source Code Biol Med. 2013;8(1):21.PubMedCentralPubMedCrossRef

40.

Wichmann HE, Kuhn KA, Waldenberger M, et al. Comprehensive catalog of European biobanks. Nat Biotechnol. 2011;29(9):795–7.PubMedCrossRef

41.

Orphanet Report Series: Disease Registries in Europe. January 2013. Available at. http://www.orpha.net/orphacom/cahiers/docs/GB/Registries.pdf . Accessed 15 April 2014.

Title: RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research
Authors: Rachel Thompson, M.Chem.
Louise Johnston, Ph.D.
Domenica Taruscio, PhD, M.D.
Lucia Monaco, Ph.D.
Christophe Béroud, PharmD, Ph.D.
Ivo G. Gut, Ph.D.
Mats G. Hansson, Ph.D.
Peter-Bram A. ’t Hoen, Ph.D.
George P. Patrinos, PhD
Hugh Dawkins, Ph.D.
Monica Ensini, Ph.D.
Kurt Zatloukal, M.D.
David Koubi, Ph.D.
Emma Heslop, M.Sc.
Justin E. Paschall, M.A.
Manuel Posada, Ph.D.
Peter N. Robinson, M.D., Ph.D.
Kate Bushby, M.D., F.R.C.P.
Hanns Lochmüller, Ph.D., M.D.
Publication date: 01-08-2014
Publisher: Springer US
Published in: Journal of General Internal Medicine / Issue Special Issue 3/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-014-2908-8

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research

ABSTRACT

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

ABSTRACT

Please log in to get access to this content

Other articles of this Special Issue 3/2014

Introduction to a Supplement on Innovative Approaches to Studying Health Outcomes in Rare Diseases

Highly Effective Cystic Fibrosis Clinical Research Teams: Critical Success Factors

Quantifying a Rare Disease in Administrative Data: The Example of Calciphylaxis

Preface to the AHRQ Supplement

Important Role of Translational Science in Rare Disease Innovation, Discovery, and Drug Development

Application of a Policy Framework for the Public Funding of Drugs for Rare Diseases

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page